Thursday, November 22, 2012

ELAY - Continues Its Rally - My Chart to Watch at $.0017

ELAY soared to new highs today as the stock continues to see strong buying pressure. Last month with ELAY sitting near its lows I brought the stock to my subscribers as a possible trade.

ELAY is a stock I highlighted last month in my charts to watch section at $.0017 --- LINK:

The stock hit $.015 today.  To put that type of move into money terms a $170 purchase of ELAY at $.0017 would be worth $1,500 at today's high and $1,140 at the close.

eLayaway, Inc. Releases 2012 Online Layaway Retail Trends Report

Layaway Shown to be Popular Across a Broad Spectrum of Retail Consumers

TALLAHASSEE, Fla., Nov 15, 2012 (BUSINESS WIRE) -- eLayaway(R), Inc. (OTCBB: ELAY) ("eLayaway" or the "Company"), parent company of DivvyTech, Inc., creators of innovative recurring payment technology solutions, specializing in online layaway services, released today its 2012 Online Layaway Trends Report in the form of a downloadable infographic. In addition to identifying and comparing both online and brick & mortar layaway programs, the infographic highlights the trends and user behavior of the Company's online layaway service,
"Layaway trends differ greatly from traditional retail trends," said Sergio Pinon, eLayaway's Founder and CEO. "The planning and budgeting aspect of the payment option provide retailers with unique marketing opportunities throughout the year. The infographic provides retailers with valuable insight to the layaway process and its effects on consumer planning and spending."
The trend report was created from user behavior observed between 11/1/2011 and 10/31/2012; what eLayaway calls a Layaway Year. The offset provides a more accurate depiction of layaway use due to the pre-payment completion cycle unique to the layaway process.
Highlights from the report include:
Online layaway appeals to a wide spectrum of consumers across several demographic segments; Electronics continue to be the most popular layaway category; November is the most popular month for starting a layaway; Layaway creates "shopping seasons" throughout the year; 63% of consumers pay off their "eLayaway" sooner than originally scheduled; Taking into account interest and fees, layaway is more affordable than credit.
Download the infographic here.
About eLayaway, Inc.
eLayaway, Inc., is a publically-traded (OTCBB: ELAY) American payment and retail technology company headquartered in Tallahassee, Florida. To learn more about eLayaway, Inc., and supported brands, please visit:
Safe Harbor Statement
This report includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for the current fiscal year and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events. Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, the frequency, magnitude and timing of any or all raw-material-price changes, general business and economic conditions beyond the Company's control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace, cost-containment strategies, and the Company's success in attracting and retaining key personnel. Additional information concerning factors that could cause actual results to differ materially from those projected is contained in the Company's filing with The Securities and Exchange C

Wednesday, November 21, 2012

KNSC on a Roll

Kenergy Scientific, Inc. Announces Breakthrough Solar Technology- Notice Of Allowance Received From United States Patent Office

FLEMINGTON, N.J., Oct. 19, 2012 /PRNewswire via COMTEX/ -- Ken Glynn, President and CEO of GreenSmart Stores and Kenergy Scientific, Inc. (PINKSHEETS: KNSC), today reported that a Notice of Allowance has been received in US patent Application serial number 12/384, 822, filed in April, 2009. This is the granddaddy patent application on third generation solar power and represents a breakthrough for both the company and the technology. Ken is the sole inventor and is very pleased that the United States Patent Office has recognized the uniqueness of the technology. First generation solar involves the use of sunlight to heat things- water pipes for hot water, heat sinks for heat storage, etc. Second generation solar is using sunlight to activate photovoltaic cells (solar panels) to generate electricity. Ken is considered the father of third generation solar, that is, the generation of electricity and motor power from sunlight without the need for solar panels or other photovoltaics. The invention relates to reciprocal motion conversion to electricity and/or motive power from controlled sun and shade temperature differentials using liquid transfer phenomena and resulting weight shifting. This patent award will significantly increase the value of Kenergy's patent portfolio.
Ken was awarded the Green Citizen of the year at the Garden State GreenFest at Kean University in 2011, for his inventions in third generation solar and for the creation of the GreenSmart Store concept and he has more than twelve eco-friendly invention patents and pending applications. He is optimistic that other Notices of Allowance will follow this one.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Monday, November 19, 2012

TGGI - $.0001 Stock Ready to Rally?

With penny stocks its all about timing an impending rally. Surely not every penny stock will rally and more often than not it will fall flat on its face. Take TGGI, this stock has been face first in thick mud for almost 2 years. Could the stock finally be pulling its face out of the mud? Recall BBDA a stock that was face first in the mud earlier this year, when suddenly the company issued positive news about its share structure. The stock was at $.0003/.0004 at the time and I alerted my subscribers of a possible move. The stock went on to break $.01 over the course of the next few months. Just a spectacular move. TGGI issued further clarification of share reductions today and we could be looking at the start of a rally for the stock short term. Today TGGI traded at $.0001 and $.0002. Could we be looking at higher prices per share down the road? I like the chances here. Trans Global Group Has Filed The Amendment To Reduce The Authorized Shares By 20 Percent CORAL SPRINGS, Fla., Nov. 19, 2012 /PRNewswire via COMTEX/ -- Trans Global Group, Inc. (PinkSheets: TGGI) is pleased to announce the Company has filed an Amendment with the State of Nevada to reduce the authorized shares of the Company from 5 billion to 4 billion shares. The Company would like to state that it will not effect any type of Reverse split or restricting of the Common stock until January 2014. The Company will look to try to reduce the number of Authorized shares again before the end of fiscal year 2012. The Company will issue further news as events unfold over the coming weeks regarding restructuring of the Company's debt. The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. CONTACT:Christopher J Clarkechris@transglobalgroupinc.com954-509-3749 SOURCE Trans Global Group, Inc.

Monday, November 12, 2012

CLNP Breaks $.01 up 1,000%+ in 3 Months

Just three months ago CLNP sat bidless with no investor interest.  Look at it today.  The stock has risen some 1,000%.  A $100 but at the lows is worth $10,000 right now.  The $.01 break is key today, lets see if it can hold it.  The stock is touching over sold territory and may pull back soon so now is not the time to chase the stock. A healthy pull back could lead to higher prices down the road.

Thursday, November 8, 2012

MDIN Continues to Rally

Northstar announces breakthrough new product line and its first product to target the $2.7 billion sports nutrition market

HOLBROOK, N.Y., Nov. 8, 2012 /PRNewswire via COMTEX/ -- Northstar Global Business Services, Inc. (PINK SHEETS: MDIN) today announced it's newest product will target the $2.7 billion annual sports nutrition market with a new stem cell replacement therapy tablet that allows individuals to build muscle many times faster than normal.
The breakthrough product uses a unique blue-green algae extract called Aphanizomenon flos-aquae (AFA), which has been proven to increase the number of free flowing adult stem cells in the human body by as many as several hundred times the norm. Company CEO, Nick Chieco Said, "This product has been researched by us for years now, and we are very excited about getting into retail stores across America along side our proven products, Snorenz� and GoodNight's Sleep�." He went on to say, "The first product in this new line, Stemintense(TM) is so exciting because it is legal, healthy, all natural, has tons of additional benefits like anti-oxidants, and according to clinical trials works better for building muscle then even the most potent steroids!" Fitness enthusiasts often flood their system with proteins, the building blocks of muscle, this product floods your system with actuals cells that can become muscle cells.
Clinical studies have shown the potential of this new supplement to be astounding, and everyone knows that fitness fanatics looking to build muscle and get larger will do, and pay almost anything to achieve their goals. The company's Stemintense(TM) product offers to do that in a safe and healthy way, something no other solution offers. Initially it will hit the shelves as a tablet but a protein shake version is also in the works as well as the licensing of Stemintense(TM) to other major protein shake and bar manufacturers as an additive. Because the product has a higher price point than the company's other products, it offers a much higher net profit margin, almost three times higher. Overall these three strategies aim to achieve 35% to 45% market saturation by 2015. This could represent hundreds of millions in revenue to the company over the three-year period.
The new product line, which Stemintense(TM) is part of is currently made up of four distinct products, which all use stem cell replacement therapy in one form or another. These products target areas of fitness, beauty, anti-aging, first aid, healing, and mental acuity, memory and intelligence. The other three products will be released later this year.
The primary role of adult stem cells in a living organism are to maintain and repair the tissue in which they are found, and the all natural ingredients used here trigger the body to mass produce these cells in different ways. The company states it has always brought new technology in alternative health to the public, and is determined to continue this trend, while taking it to new heights.
About NorthstarNorthstar Global Business Services, Inc. owns and produces alternative healthcare products through its "Medgen" division. Among it's products are the popular "Snorenz�", Painenz�, and "Goodnight's Sleep�" which have sold as many as five million units annually in the past through both direct sales and nationwide retail chains such as Walmart(TM), CVS(TM), and Walgreen's(TM).
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.
For more information on Stemintense(TM) visit: email: